Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 108

1.

Cell cycle regulators in testicular cancer: loss of p18INK4C marks progression from carcinoma in situ to invasive germ cell tumours.

Bartkova J, Thullberg M, Rajpert-De Meyts E, Skakkebaek NE, Bartek J.

Int J Cancer. 2000 Feb 1;85(3):370-5.

2.

Deregulation of the G1/S-phase control in human testicular germ cell tumours.

Bartkova J, Rajpert-De Meyts E, Skakkebaek NE, Lukas J, Bartek J.

APMIS. 2003 Jan;111(1):252-65; discussion 265-6. Review.

PMID:
12760379
3.

Regulation of cyclin dependent kinase inhibitor proteins during neonatal cerebella development.

Watanabe G, Pena P, Shambaugh GE 3rd, Haines GK 3rd, Pestell RG.

Brain Res Dev Brain Res. 1998 Jun 15;108(1-2):77-87.

PMID:
9693786
4.

Involvement of p21(WAF1/Cip1), p27(Kip1), and p18(INK4c) in troglitazone-induced cell-cycle arrest in human hepatoma cell lines.

Koga H, Sakisaka S, Harada M, Takagi T, Hanada S, Taniguchi E, Kawaguchi T, Sasatomi K, Kimura R, Hashimoto O, Ueno T, Yano H, Kojiro M, Sata M.

Hepatology. 2001 May;33(5):1087-97.

PMID:
11343236
6.

Cooperation of p27(Kip1) and p18(INK4c) in progestin-mediated cell cycle arrest in T-47D breast cancer cells.

Swarbrick A, Lee CS, Sutherland RL, Musgrove EA.

Mol Cell Biol. 2000 Apr;20(7):2581-91.

8.

The expression of p18INK4 and p27kip1 cyclin-dependent kinase inhibitors is regulated differently during human B cell differentiation.

Schrantz N, Beney GE, Auffredou MT, Bourgeade MF, Leca G, Vazquez A.

J Immunol. 2000 Oct 15;165(8):4346-52.

9.
10.

Role of cyclin-dependent kinases and their inhibitors in cellular differentiation and development.

Chellappan SP, Giordano A, Fisher PB.

Curr Top Microbiol Immunol. 1998;227:57-103. Review. No abstract available.

PMID:
9479826
11.

Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/Cip1) by STAT5.

Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa J, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y.

Mol Cell Biol. 1997 May;17(5):2933-43.

12.

CDK inhibitors: positive and negative regulators of G1-phase progression.

Sherr CJ, Roberts JM.

Genes Dev. 1999 Jun 15;13(12):1501-12. Review. No abstract available.

13.

Involvement of p21 and p27 in the regulation of CDK activity and cell cycle progression in the regenerating liver.

Albrecht JH, Poon RY, Ahonen CL, Rieland BM, Deng C, Crary GS.

Oncogene. 1998 Apr 23;16(16):2141-50.

14.
15.

Reduced p18INK4c, p21CIP1/WAF1 and p27KIP1 mRNA levels in tumours of primary and secondary hyperparathyroidism.

Buchwald PC, Akerström G, Westin G.

Clin Endocrinol (Oxf). 2004 Mar;60(3):389-93.

PMID:
15009006
16.

Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.

Korkolopoulou P, Christodoulou P, Konstantinidou AE, Thomas-Tsagli E, Kapralos P, Davaris P.

Hum Pathol. 2000 Jun;31(6):751-60.

PMID:
10872671
18.

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.

Sangfelt O, Erickson S, Castro J, Heiden T, Gustafsson A, Einhorn S, Grandér D.

Oncogene. 1999 May 6;18(18):2798-810.

19.

p18(INK4c) collaborates with other CDK-inhibitory proteins in the regenerating liver.

Luedde T, Rodriguez ME, Tacke F, Xiong Y, Brenner DA, Trautwein C.

Hepatology. 2003 Apr;37(4):833-41.

PMID:
12668976
20.

Genetic status and expression of the cyclin-dependent kinase inhibitors in human gastric carcinoma cell lines.

Akama Y, Yasui W, Kuniyasu H, Yokozaki H, Akagi M, Tahara H, Ishikawa T, Tahara E.

Jpn J Cancer Res. 1996 Aug;87(8):824-30.

PMID:
8797888
Items per page

Supplemental Content

Write to the Help Desk